James F Tessmer Lexicon Pharmaceuticals, Inc. (LXRX) insider trading activity

LXRX Quotes by TradingView

James F Tessmer is VP, Finance & Accounting of LEXICON PHARMACEUTICALS, INC.. Currently has a direct ownership of 71,766 shares of LXRX, which is worth approximately $59,565. The most recent transaction as insider was on Mar 15, 2021, when has been sold 22,912 shares (Common Stock) at a price of $6.91 per share, resulting in proceeds of $158,322. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 71.8K
0% 3M change
0% 12M change
Total Value Held $59,565

James F Tessmer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 15 2021
SELL
Open market or private sale
$158,322 $6.91 p/Share
22,912 Reduced 24.2%
71,766 Common Stock
Mar 15 2021
BUY
Exercise of conversion of derivative security
$39,720 $3.31 p/Share
12,000 Added 12.53%
83,766 Common Stock
Feb 28 2021
SELL
Payment of exercise price or tax liability
$77,400 $7.19 p/Share
10,765 Reduced 11.52%
82,678 Common Stock
Feb 28 2021
BUY
Exercise of conversion of derivative security
-
28,316 Added 23.26%
93,443 Common Stock
JFT

James F Tessmer

VP, Finance & Accounting
The Woodlands, TX

Track Institutional and Insider Activities on LXRX

Follow LEXICON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXRX shares.

Notify only if

Insider Trading

Get notified when an Lexicon Pharmaceuticals, Inc. insider buys or sells LXRX shares.

Notify only if

News

Receive news related to LEXICON PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LXRX